MELANIE HINKLE: Open Payments
NPI 1700158508 · LOW MOOR, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$357 in 19 payments from 13 companies in 2025. Trend: 2023 $310 · 2024 $410 · 2025 $357
Food & beverage: $337Education: $20
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $71 |
| Travere Therapeutics, Inc. | 3 | $66 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| Novo Nordisk Inc | 1 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Ardelyx, Inc. | 1 | $19 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Boston Scientific Corporation | 1 | $17 |
| Ascendis Pharma Endocrinology Inc | 1 | $15 |
Products named: FARXIGA, Kerendia, Wegovy, ENTYVIO, IBSRELA, LifeVest, JYNARQUE, WATCHMAN FLX.
Industry payments across VA — which companies pay providers there.
